InfuSystems Holdings, Inc. (INFU) closed the last trading session at $9.57, gaining 59.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $13.5 indicates a 41.1% upside potential.The average comprises five short-term price targets ranging from a low of $12.00 to a high of $15.00, with a standard deviation of $1.41. While the lowest estimate indicates an increase of 25.4% from the c ...

Shares of Superior Group (SGC) have gained 18.5% over the past four weeks to close the last trading session at $13.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18 indicates a potential upside of 38.4%.The average comprises five short-term price targets ranging from a low of $14.00 to a high of $24.00, with a standard deviation of $4. While the lowest estimate indicates a ...

Shares of Astria Therapeutics, Inc. (ATXS) have gained 8.3% over the past four weeks to close the last trading session at $6.76, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $29.33 indicates a potential upside of 333.9%.The average comprises nine short-term price targets ranging from a low of $16.00 to a high of $49.00, with a standard deviation of $9.19. While the lowest est ...

Core Viewpoint - Tourmaline Bio, Inc. (TRML) has shown a significant price increase of 20.4% over the past four weeks, with a mean price target of $56.2 indicating a potential upside of 151% from the current trading price of $22.39 [1] Price Targets and Analyst Estimates - The mean estimate consists of 10 short-term price targets with a standard deviation of $10.22, where the lowest estimate of $35.00 suggests a 56.3% increase, and the highest estimate of $70.00 indicates a potential surge of 212.6% [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts are optimistic about TRML's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which has historically correlated with near-term stock price movements [11] - Over the last 30 days, one estimate has increased, leading to a 0.6% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - TRML holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside in the near term [13]

Core Viewpoint - Deluxe (DLX) has shown a significant price increase of 21.5% over the past four weeks, with a mean price target of $26.75 indicating a potential upside of 37% from its current price of $19.52 [1] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $2.75, where the lowest estimate is $24.00 (23% increase) and the highest is $30.00 (53.7% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - There is a growing optimism among analysts about DLX's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 5.2%, with one estimate moving higher and no negative revisions [12] Zacks Rank and Investment Potential - DLX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential for upside in the near term [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a useful guide for the direction of price movement [14]

Group 1 - ExlService Holdings (EXLS) shares have increased by 2.8% in the past four weeks, closing at $42.54, with a mean price target of $54.71 indicating a potential upside of 28.6% [1] - The average price targets from analysts range from a low of $52.00 to a high of $56.00, with a standard deviation of $1.5, suggesting a relatively high agreement among analysts regarding the stock's price movement [2][9] - Analysts are optimistic about EXLS's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a strong correlation with near-term stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for EXLS's current year earnings has increased by 3.9% over the past month, with six estimates revised upward and no negative revisions [12] - EXLS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential for upside in the near term [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Group 1 - Varex Imaging (VREX) shares have increased by 23.2% in the past four weeks, closing at $9.77, with a mean price target of $16.75 indicating a potential upside of 71.4% [1] - The average price targets range from a low of $10.00 to a high of $23.00, with a standard deviation of $5.38, suggesting variability in analyst estimates [2] - Analysts are optimistic about VREX's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for VREX's current year earnings has increased by 31% over the past month, with no negative revisions [12] - VREX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can provide guidance on the direction of price movement [14]

Core Insights - W.W. Grainger, Inc. reported weaker-than-expected earnings for Q2, with earnings per share (EPS) of $9.97, missing the analyst consensus estimate of $10.04, while quarterly sales of $4.554 billion exceeded the estimate of $4.522 billion [1] - The company revised its FY2025 GAAP EPS guidance down from a range of $39.00-$41.50 to $38.50-$40.25, but raised its sales guidance from $17.600 billion-$18.100 billion to $17.900 billion-$18.200 billion [2] - CEO D.G. Macpherson emphasized the company's focus on customer relationships and innovation, noting that performance was affected by tariff-related factors, but expressed confidence in the company's ability to create value amid macroeconomic uncertainty [3] Analyst Reactions - Following the earnings announcement, RBC Capital analyst Deane Dray maintained a Sector Perform rating on W.W. Grainger and lowered the price target from $1,176 to $1,007 [6] - Loop Capital analyst Chris Dankert also maintained a Hold rating and reduced the price target from $1,000 to $950 [6]

Core Viewpoint - Accel Entertainment (ACEL) shares have increased by 3% recently, with a mean price target of $16 indicating a potential upside of 28.2% from the current price of $12.48 [1][2]. Price Targets and Analyst Consensus - The average price target for ACEL is $16, with a standard deviation of $0, indicating strong agreement among analysts [2]. - The lowest and highest estimates both suggest a 28.2% upside from the current price level, reflecting a consensus among analysts [2][4]. - Despite the consensus price target being a useful metric, relying solely on it for investment decisions may not be prudent due to historical inaccuracies in analysts' price targets [3][7]. Earnings Estimates and Market Sentiment - Analysts show strong agreement in revising ACEL's earnings estimates higher, which is a positive indicator for potential stock upside [4][11]. - Over the past 30 days, the Zacks Consensus Estimate for ACEL's current year earnings has increased by 2%, with no negative revisions [12]. - ACEL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a favorable outlook [13]. Conclusion on Price Movement - While the consensus price target may not reliably predict the extent of ACEL's gains, the direction indicated by the price movement appears to be a valid guide for potential investment [14].

Group 1 - Hillman Solutions Corp. (HLMN) closed at $8, with a 5.3% gain over the past four weeks, and has a mean price target of $10.94, indicating a 36.8% upside potential [1] - The mean estimate consists of eight short-term price targets with a standard deviation of $2.54, where the lowest estimate is $8.00 and the highest is $15.00, suggesting an 87.5% potential increase [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as indicated by a 0.6% increase in the Zacks Consensus Estimate for the current year [11][12] Group 2 - HLMN has a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - The clustering of price targets with a low standard deviation suggests a high degree of agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] - While price targets should not be the sole basis for investment decisions, the direction they imply appears to be a good guide for potential price movements [14]